Guide

Meet with our MedTech and Oncology Experts, Charlie Chrisawn and Meera Belur

Charlie Chrisawn

Executive Director, Diagnostics

Charlie Chrisawn has spent his entire career focused on diagnostic development and has amassed over 15 years of experience designing and leading diagnostic trials including sample collection, validation, and utility studies. Mr. Chrisawn’s background consists of both small- and large-scale diagnostics studies, including management of all development stages of diagnostics across a range of study settings. Under Charlie’s leadership, Premier Research celebrated a milestone achievement enrolling 100,000 participants in their diagnostic studies worldwide.

Mr. Chrisawn’s programs have successfully garnered MA and 510(K) approvals, including the only FDA approved screening test for Colorectal Cancer and the first FDA cleared at-home test for COVID-19. Mr. Chrisawn has also enabled dual 510(k)/CLIA study execution and drug/device combination studies in the 505(b)(2) pathway. His expertise includes protocol and study design, domestic and international study startup, site management, sample accountability, staff training, and study closure.

Mr. Chrisawn earned a Bachelor of Science (BS) degree in Biology from Davidson College.

Meera Belur

Executive Director, Oncology Program Strategy

Meera Belur is an integral member of the oncology leadership team, responsible for providing strategic planning, coordination, knowledge, and expertise for Oncology & Hematology projects. She brings more than 20 years of industry experience in academia, small biotech firms, large pharmaceutical companies, and CROs.

Before joining Premier Research, Ms. Belur served as the Portfolio Group Head for a large pharmaceutical company, overseeing Radioligand, CAR-T, and Gene Therapy assets within the Oncology business unit. She has a diverse background in Global Clinical Operations, Drug Development, and Project Management, with a proven track record of providing strategic leadership and successfully managing multiple aspects of numerous global phase 1-4 clinical trials across various therapeutic areas. Meera is renowned for building and maintaining top-tier project management teams.

Continue this conversation with a Premier expert

Learn more about our strategic capabilities.